Wikidata

(Q61935998)

English

A Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma

clinical trial

In more languages

Statements

title
A Phase I/II Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma (English)
0 references
start time
July 2010
0 references
end time
July 2013
0 references
number of participants
17
0 references
research intervention
doxorubicin
0 references
Caelyx
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61935998&oldid=2149091375"